Navigation Links
BioMarin Announces FDA Approval for Kuvan
Date:12/13/2007

le for PKU patients. For more information about the BioMarin Patient and Physician Support Program, please call 877-MY-KUVAN (877.695.8826). For more information about Kuvan, please visit http://www.Kuvan.com.

Conference Call

BioMarin will host a conference call and webcast to discuss the Kuvan approval today, Thursday, December 13, at 5:00 p.m. ET. This event can be accessed on the investor section of the BioMarin website at http://www.BMRN.com.

Date: December 13, 2007

Time: 5:00 p.m. ET

U.S. / Canada Dial-in Number: 800.510.9661

International Dial-in Number: 617.614.3452

Participant Code: 95299072

Replay Dial-in Number: 888.286.8010

Replay International Dial-in Number: 617.801.6888

Replay Code: 61294597

About Kuvan

Kuvan(TM) (sapropterin dihydrochloride) Tablets is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.

The active ingredient in Kuvan, sapropterin dihydrochloride, is the synthetic form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe. BioMarin and Merck Serono estimate that Kuvan could be a potential treatment option for approximately 30 percent to 50 percent of the estimated 50,000 identified PKU patients in the developed world.

Kuvan has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). Kuvan has received seven years of market exclusivity in the United States. In November 2007, Merck Serono submitted a Marketing Authorization Application (MAA) to the EMEA for sapropterin dihydrochloride as an oral treatm
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses of ... services organization, is hosting its tenth annual "Triumph For ... June 6, 2013.  More than 300 people are expected ... adolescent residential treatment centers, family therapy, and prevention programs ... accomplishments have positive influences on the health and welfare of ...
(Date:5/24/2013)... , May 24, 2013 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... recently learned from a public announcement issued by Shanghai ... company listed on Shenzhen Stock Exchange, that on May ... ("Ms. Chan"), one of the shareholders of the ...
(Date:5/24/2013)... May 24, 2013 The potential ... systemic delivery of therapeutic agents has been receiving undeniable ... delivery showing significant promise. The crucial formulation considerations for ... device play a major role in the efficiency of ... the development of new formulation techniques and devices in ...
Breaking Medicine Technology:Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... (AMEX: ISR ), a medical technology company ... for brain cancer, lung cancer, head and neck cancer ... and Chief Executive Officer, will co-present at RetailInvestorConferences.com. ... PM EST LINK:   www.retailinvestorconferences.com > ...
...   Leatt Corporation (OTC: LEAT.PK), a global marketer ... designed to help prevent potentially devastating injuries to the ... formation of an agreement with Whites Powersports for the ... Whites Powersports has more than 50 years experience in ...
Cached Medicine Technology:IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st 2Leatt Announces Distribution Agreement With Whites Powersports for New Zealand Market 2
(Date:5/25/2013)... May 25, 2013 By working diligently ... declared the integration of the 2012 Lamborghini Aventador into ... the latest entrant in the list of vehicles lined ... vehicle is all set to thrill automobile lovers in ... power and spectacular looks, the 2012 Lamborghini Aventador comes ...
(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra ... women that ever lived. Cleopatra’s legendary beauty moved nations ... most powerful men in her time. Cleopatra was also ... her skin glowing and fresh, from her legendary milk ... oil and cyprus grass. , Cleopatra was said to ...
(Date:5/25/2013)... 25, 2013 For college students, ... week. Increasingly, they are turning to prescription stimulants ... study. For more on this, go to ... facility, warns that students who pick up Adderall, ... risk for developing a physical and psychological dependency. ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 HealthCrave ... that is unique in that it doesn’t just ... focuses on treating what causes the noticeable signs ... physician Dr. James D. Weiss, M.D., the center ... aging process while helping patients to live longer, ...
(Date:5/24/2013)... A recent study by research group Harris Interactive found that ... season. Almost 138 million people are fearful of pulling on ... issues and a quarter admit they feel pressured to lose ... those anxious about their size consider the over the counter ... effort to improve diet and exercise habits ahead of peak ...
Breaking Medicine News(10 mins):Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3
... HealthDay Reporter , MONDAY, Sept. 26 (HealthDay News) ... brain size and more problems with thinking skills as people ... who suffer from B-12 deficiencies may be greater than thought ... not be accurate, said Christine C. Tangney, lead author of ...
... study shows that 145,000 deaths could be averted in ... stronger tobacco control policies. This set of policies, as ... Organisation, consists of increasing tobacco taxes to 70% of ... public places, a complete marketing ban, well-funded tobacco control ...
... cancer patients who use a new combination of the ... Gy) before surgery have an 88 percent chance of ... randomized trial presented at the plenary session, October 3, ... Society for Radiation Oncology (ASTRO). "The results of ...
... 26, 2011 Notable levels of calcium buildup in coronary ... in people with diabetes and metabolic syndrome, according to a ... The researchers also found that individuals with diabetes or metabolic ... as low as many without these conditions. Supported by ...
... treatment for one form of albinism? Individuals ... pale skin, and light-colored irises because they have none, or ... and eyes. Affected individuals have impaired eyesight and a substantially ... to attempts to correct eyesight and counseling to promote the ...
... health challenges earlier than their fellow seniors, researchers ... lives of 8,700 older people, a Case Western ... reported physical limitations by African American women in ... finding surfaced as researchers looked generally at how ...
Cached Medicine News:Health News:Could Too Little Vitamin B-12 Shrink the Aging Brain? 2Health News:Could Too Little Vitamin B-12 Shrink the Aging Brain? 3Health News:Stronger tobacco control policy in the Netherlands would save thousands of lives 2Health News:Chemo plus radiation before surgery increases tumor response for rectal cancer 2Health News:JCI online early table of contents: September 26, 2011 2Health News:JCI online early table of contents: September 26, 2011 3Health News:JCI online early table of contents: September 26, 2011 4Health News:JCI online early table of contents: September 26, 2011 5Health News:JCI online early table of contents: September 26, 2011 6Health News:JCI online early table of contents: September 26, 2011 7Health News:African-American women develop functional challenges earlier than others 2Health News:African-American women develop functional challenges earlier than others 3
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 23G x 7/8 in (.60 x 22mm). .3mm end port. Olive shape tip is 2mm long x 1mm w...
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)...
For administering local anesthetic prior to ophthalmic surgery. 27G x 1 1/4 in (.40 x 32mm). May also be used for retrobulbar administration....
... is a complete vestibular diagnostic system ... movements collected via electrodes. Its Windows-based ... use. Saccade, tracking and Slow Phase ... is facilitated by graphic comparison of ...
Medicine Products: